title: NICE recommends new triple therapy option for type 2 diabetes.
authors.affiliation: London.
authors.forename: Jacqui
authors.initials: J
authors.lastname: Wise
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005960:Glucosides / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D006113:United Kingdom
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; C529054:dapagliflozin; D008687:Metformin